The traditional value chain for pharmaceutical companies has included drug discovery, development, marketing, manufacturing, and distribution of prescription products to wholesalers. Good clinical practices (GCP), good manufacturing practices (GMP), and disciplined marketing plans minimize inappropriate variability in the development, production, and communication of pharmaceuticals. However, the ultimate delivery of care — including selection and use of the drug — has been the sole domain of individual physicians. The inevitable variability in diagnostic approaches, patient selection, side effect management, patient counseling, and patient management profoundly change product performance. Individual clinicians may have very different experiences with drug effectiveness, safety, utilization, and patient satisfaction.

In short, the care delivery gap leads to a product performance gap. ParagonRx^® uniquely addresses the care delivery gap. The insight derived from our clinical observations informs the design of procedures, techniques, and tools that improve care delivery and product performance.

To discuss how ParagonRx can bridge the gap in your product's value chain, contact ParagonRx.